KC

Keya Chowdhury

Active Director Director DIN 00919430
DIN 00919430 First appointment Mar 1967 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 1967
Shareholding value β€’β€’β€’β€’ Premium profile

About Keya Chowdhury

Data last updated:

Keya Chowdhury is a Director at Caldern Pharmaceuticals Ltd (since 1967). The company operates in Healthcare.

DIN 00919430
Primary Designation Director
Industry Healthcare
First Appointment 02 Mar 1967
Oldest Company Age 77 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Caldern Pharmaceuticals Ltd U85195WB1949PLC018179
Director02 Mar 19671949Active

Board colleagues of Keya Chowdhury

Directorship timeline

Open interactive timeline →
Caldern Pharmaceuticals Ltd
Premium access

Shareholding and investment profile for Keya Chowdhury

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Keya Chowdhury

Keya Chowdhury currently holds 1 directorship: Caldern Pharmaceuticals Ltd (Director, since 02 Mar 1967).

Keya Chowdhury was first appointed on 02 Mar 1967 as Director at Caldern Pharmaceuticals Ltd.

The current boards of Keya Chowdhury's companies include Ajay Kumar Chowdhury (Caldern Pharmaceuticals Ltd), Purnendushekhar Chakraborty (Caldern Pharmaceuticals Ltd).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available